DeSciNYC: Genome Editing in Early Human Embryos
Genome editing tools allow the introduction of precise changes in the DNA. For this ability, they became indispensable for basic biological research and hold great promise for future therapeutic applications. The same technologies are being utilized also in early human embryos for better understanding of key developmental regulators and DNA repair mechanisms. In the future, precise correction of specific genes might enable curing devastating diseases early in the development or decreasing the risks of certain diseases. Although continuous research is needed before such an intervention becomes safe, the first gene-edited babies were already born. This talk aims to contribute to the debate about human germline gene editing by putting it into a broader context of human biology, discussing the benefits, current limitations, and possible future alternatives leading to the prevention of genetic diseases.
---------
Dr. Diego Marin is the Deputy Director and Head of Global Business Development & Scientific Affairs at Genomic Prediction. He holds a PhD in Genetics and Cancer Biology. In addition to his industry role, he serves as an Adjunct Professor in the Department of Genetics at Rutgers University
🐦Stay Connected about Future Events:
Twitter: @descinyc_
Instagram: @descinyc
PS: Apply to be a member of the DeSci NYC group chat: https://forms.gle/AmUtotmCgWgGxWDp6